These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29371123)

  • 1. Methodologies for assessing the acceptability of oral formulations among children and older adults: a systematic review.
    Ranmal SR; O'Brien F; Lopez F; Ruiz F; Orlu M; Tuleu C; Walsh J; Liu F
    Drug Discov Today; 2018 Apr; 23(4):830-847. PubMed ID: 29371123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populations.
    Liu F; Ranmal S; Batchelor HK; Orlu-Gul M; Ernest TB; Thomas IW; Flanagan T; Tuleu C
    Drugs; 2014 Oct; 74(16):1871-1889. PubMed ID: 25274536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of therapeutic patient education on adherence to oral anti-cancer medicines in adult cancer patients in ambulatory care settings: a systematic review.
    Arthurs G; Simpson J; Brown A; Kyaw O; Shyrier S; Concert CM
    JBI Database System Rev Implement Rep; 2015 Jun; 13(5):244-92. PubMed ID: 26455611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of formulation factors that affect oral medicines acceptability in a domiciliary paediatric population.
    Venables R; Batchelor H; Hodson J; Stirling H; Marriott J
    Int J Pharm; 2015 Mar; 480(1-2):55-62. PubMed ID: 25601436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptability of oral solid medicines in older adults with and without dysphagia: A nested pilot validation questionnaire based observational study.
    Liu F; Ghaffur A; Bains J; Hamdy S
    Int J Pharm; 2016 Oct; 512(2):374-381. PubMed ID: 26970368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation factors affecting acceptability of oral medicines in children.
    Liu F; Ranmal S; Batchelor HK; Orlu-Gul M; Ernest TB; Thomas IW; Flanagan T; Kendall R; Tuleu C;
    Int J Pharm; 2015 Aug; 492(1-2):341-3. PubMed ID: 25959115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the pharmaceutical technologic aspects of oral pediatric drugs on patient-related outcomes: a systematic literature review.
    van Riet-Nales DA; Schobben AF; Egberts TC; Rademaker CM
    Clin Ther; 2010 May; 32(5):924-38. PubMed ID: 20685501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Problems with oral formulations prescribed to children: a focus group study of healthcare professionals.
    Venables R; Stirling H; Batchelor H; Marriott J
    Int J Clin Pharm; 2015 Dec; 37(6):1057-67. PubMed ID: 26173937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers to administering non-oral formulations in a paediatric population: A semi-structured interview study.
    Venables R; Batchelor H; Stirling H; Marriott J
    Int J Pharm; 2016 Jan; 497(1-2):12-7. PubMed ID: 26611666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The application of tribology in assessing texture perception of oral liquid medicines.
    Batchelor H; Venables R; Marriott J; Mills T
    Int J Pharm; 2015 Feb; 479(2):277-81. PubMed ID: 25575471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Oral formulation of choice for children].
    Lajoinie A; Henin E; Kassai B
    Arch Pediatr; 2015 Aug; 22(8):877-85. PubMed ID: 26141805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Factors influencing the acceptability of pediatric galenic formulations].
    Rehn C; Odouard E; Poncet F; Cochat P; Breant V; Dode X
    Ann Pharm Fr; 2018 May; 76(3):163-171. PubMed ID: 29502801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmaceutical strategies towards optimising polypharmacy in older people.
    Hughes CM; Cadogan CA; Patton D; Ryan CA
    Int J Pharm; 2016 Oct; 512(2):360-365. PubMed ID: 26921516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods of administering oral formulations and child acceptability.
    van Riet-Nales DA; Ferreira JA; Schobben AF; de Neef BJ; Egberts TC; Rademaker CM
    Int J Pharm; 2015 Aug; 491(1-2):261-7. PubMed ID: 26143234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of acceptability of oral paediatric medicines: a review.
    Mistry P; Batchelor H;
    J Pharm Pharmacol; 2017 Apr; 69(4):361-376. PubMed ID: 27524471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosage form suitability in vulnerable populations: A focus on paracetamol acceptability from infants to centenarians.
    Ruiz F; Vallet T; Dufaÿ Wojcicki A; Belissa É; Fontan JE; de Pontual L; Nathanson S; Chevallier A; Laribe-Caget S; Boudy V
    PLoS One; 2019; 14(8):e0221261. PubMed ID: 31430323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-centred, administration friendly medicines for children - an evaluation of children's preferences and how they impact medication adherence.
    Bryson SP
    Int J Pharm; 2014 Aug; 469(2):257-9. PubMed ID: 24797763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric drug formulations: a review of challenges and progress.
    Ivanovska V; Rademaker CM; van Dijk L; Mantel-Teeuwisse AK
    Pediatrics; 2014 Aug; 134(2):361-72. PubMed ID: 25022739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-appropriate and acceptable paediatric dosage forms: Insights into end-user perceptions, preferences and practices from the Children's Acceptability of Oral Formulations (CALF) Study.
    Ranmal SR; Cram A; Tuleu C
    Int J Pharm; 2016 Nov; 514(1):296-307. PubMed ID: 27863675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of swallowability and palatability of oral dosage forms in children: Report from an M-CERSI pediatric formulation workshop.
    Ternik R; Liu F; Bartlett JA; Khong YM; Thiam Tan DC; Dixit T; Wang S; Galella EA; Gao Z; Klein S
    Int J Pharm; 2018 Feb; 536(2):570-581. PubMed ID: 28844897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.